drugset / Trial / NCT07461532
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Apixaban is effective and safe in the treatment of portal vein thrombosis Occurring more than one year after laparoscopic splenectomy and azygoportal disconnection.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2027-09-30
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apixaban | Small molecule | 2.5 mg | Oral |